Humana Inc vs iShares Semiconductor ETF — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while iShares Semiconductor ETF trades at $535.35. The key difference: Humana Inc pays a 0.92% dividend while iShares Semiconductor ETF pays none, and Humana Inc is trading nearer its 52-week high, iShares Semiconductor ETF nearer its low. Which is the better fit depends on your goals.
| HUM | SOXX | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Sector/Thematic |
52-Week High | $409.42 | $655.01 |
52-Week Low | $163.67 | $241.68 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
SOXX trades at $543.27, up 2.02% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF faces volatility, having plunged 21% in July amid sector rotation out of chips, though major cloud company earnings support AI spending. Support sits at $534, resistance at $550. A dividend of $0.28 is scheduled for June 2026.
Outlook is cautious; semiconductor demand is buoyed by AI, but high concentration in mega-caps and competitive pressures pose risks. Investor sentiment is mixed, with institutional buying offset by concerns over valuation and China's AI advancements. Near-term performance hinges on broader tech trends and Fed policy.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →